FEATURES OF THE ESTIMATION OF THE HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSIS
Keywords:
liver cirrhosis, hepatic encephalopathy, critical flicker frequency, portosystemic shuntingAbstract
Purpose. To determine the features of assessing the severity of hepatic encephalopathy in patients with liver cirrhosis. Material and methods. The study included 490 patients with liver cirrhosis. The criterion for assessing the severity of hepatic encephalopathy at the stages of portosystemic shunting was the results of determining the critical flicker frequency obtained using the HEPAtonormTM-Analyzer. All patients were operated on in a planned manner: selective shunting (distal splenorenal anastomosis) - 306 (62.4%); central - 184 (37.6%): proximal splenorenal anastomosis with splenectomy - 13 (2.7%); latero-lateral splenorenal anastomosis - 62 (12.7%); splenosuprarenal anastomosis - 84 (17.1%); H-splenorenal anastomosis - 25 (5.1%). Results. In 100.0% of cases, portosystemic shunting worsens the rate of critical flicker (from 39.5 ± 0.9 to 37.8 ± 1.2 Hz, P <0.001), and if before the operation, hepatic encephalopathy was absent or was in latent form in 76.3% of patients, already in the early stages after the intervention, this figure decreased to 46.7%, and the majority of patients had clinically significant signs of hepatic encephalopathy. Against the background of postoperative conservative therapy, the tendency to improve the level of the critical flicker rate was more pronounced after selective portosystemic shunting (39.5 ± 1.1 Hz), whereas in the group of patients with central decompression the rate of critical flicker improves with less intensity, reaching discharge moment is only 38.3 ± 1.2 Hz (P <0.001). Conclusions. The level of the critical flicker frequency when planning for system-bypass shunting is of fundamental importance, which leads to a high probability of the development of postoperative severe liver failure with initially low rates.
References
Ивашкин В.Т. Болезни печени и желчевыводящих путей: Руководство для врачей. - 2-е изд. - Москва.: Изд. дом «М-Вести». 2005; 536 с.
Шерлок Ш., Дули Дж. Заболевания печени и жёлчных путей. – М.: ГЭОТАР-МЕД. 2002; 148-149.
Буеверов А.О., Маевская М.В. Трудные вопросы диагностики и лечения печеночной энцефалопатии. Клин. перспект. гастроэнтерол. и гепатол. 2005; 1: 25-30.
American Association for the Study of Liver Diseases. European Association for the Study of the Liver Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol. 2014;61(3):642–659.
Dharel N, Bajaj JS. Definition and nomenclature of hepatic encephalopathy. J Clin Exp Hepatol. 2015;5(1): 37-41
Ferenci P. Hepatic encephalopathy. Gastroenterology Report. 2017; 5(2): 138-147.
Jepsen P, Ott P, Andersen PK, Sorensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2010;51(5):1675-1682.
Nabi E, Thacker LR, Wade JB, et al. Diagnosis of covert hepatic encephalopathy without specialized tests. Clin Gastroenterol Hepatol. 2014;12(8):1384-89.
Schmid M, Peck-Radosavljevic M, König F, Mittermaier C, Gangl A, Ferenci P. A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis. Liver Int., 2010; 30: 574–582.
Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. American Journal of Gastroenterology, 2012; 107: 247-252.